研究单位：[1]Chengdu University of Traditional Chinese Medicine[2]Chongqing Taiji Group of Fuling pharmaceutical Co., LTD[3]Beijing Tongren Hospital of Capital Medical University,Beijing,China[4]Daping Hospital of Third Military Medical University,Chongqing,Chongqing,China[5]Guangdong Province Traditional Medical Hospital,Guangzhou,Guangdong,China[6]The first affiliated hospital of Hunan University of TCM,Changsha,Hunan,China[7]Jiangsu Province Traditional Medical Hospital,,Nanjing,Jiangsu,China[8]Affiliated Hospital of Chengdu University of TCM,Chengdu,Sichuan,China[9]West China Hospital,Chengdu,Sichuan,China[10]The first affiliated hospital of Guangzhou university of TCM,Guangzhou,China
Objectives of study: To preliminarily evaluate the efficacy and safety of Qideng Mingmu Capsule in the treatment of patients with diabetic retinopathy (deficiency of Qi-Yin syndrome, blood stasis syndrome), to discuss the appropriate dose and period of treatment.
